Medicare Enrolled
Dr. Galina Vugman, MD
Hematology & Oncology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vugman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vugman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vugman
Dr. Galina Vugman is a hematology & oncology specialist in Sarasota, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vugman performed 85,852 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Vugman received a total of $2,521 from 29 pharmaceutical and/or device companies across 74 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vugman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 9% volume in FL
$2,521 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 103860 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗85,852
Medicare services
Top 9% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
52,530 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 11,800 | $42 | $123 |
| Denosumab injection (Prolia/Xgeva) | 5,100 | $18 | $48 |
| Paclitaxel chemotherapy injection | 4,809 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,140 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,520 | $6 | $21 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,451 | $1 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
853 | $92 | $202 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
606 | $61 | $135 |
| Anti-nausea injection (ondansetron/Zofran) | 488 | $0 | $1 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
393 | $2 | $8 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
369 | $98 | $327 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
294 | $8 | $22 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
287 | $8 | $14 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
281 | $10 | $30 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
266 | $22 | $74 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
224 | $10 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
216 | $133 | $279 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
169 | $48 | $154 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
155 | $64 | $138 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
137 | $50 | $152 |
| New patient office visit, complex (60-74 min) | 118 | $165 | $412 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
114 | $7 | $59 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $124 | $328 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
101 | $14 | $60 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
87 | $15 | $50 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
87 | $22 | $69 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
83 | $13 | $39 |
| Iron level test | 83 | $6 | $18 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
79 | $9 | $24 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
75 | $137 | $386 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
70 | $1 | $3 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
69 | $49 | $172 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 57 | $138 | $545 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
56 | $2 | $6 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
55 | $23 | $80 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
54 | $1 | $6 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
48 | $12 | $49 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
44 | $43 | $147 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
42 | $93 | $198 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
39 | $24 | $125 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $10 | $33 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
32 | $15 | $43 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
32 | $5 | $11 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
30 | $40 | $76 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
29 | $16 | $48 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
25 | $14 | $42 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
21 | $9 | $25 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
19 | $6 | $18 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
18 | $4 | $10 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
16 | $3 | $8 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
14 | $25 | $71 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
12 | $15 | $40 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $34 | $81 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
62.4% high complexity
33.2% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,521
Total received (2018-2024)
Avg $420/year across 6 years
Bottom 41% in FL for hematology & oncology
29
Companies
74
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,072
2023
$900
2022
$110
2021
$12
2019
$289
2018
$137
Payments by company (2024)
Lilly USA, LLC
$171
Celgene Corporation
$125
GENZYME CORPORATION
$122
Novartis Pharmaceuticals Corporation
$116
Merck Sharp & Dohme LLC
$57
Incyte Corporation
$52
PFIZER INC.
$51
Alnylam Pharmaceuticals Inc.
$48
Myriad Genetic Laboratories, Inc.
$47
Janssen Biotech, Inc.
$35
E.R. Squibb & Sons, L.L.C.
$27
ACCORD HEALTHCARE, INC.
$23
ARRAY BIOPHARMA INC
$22
Daiichi Sankyo Inc.
$22
AstraZeneca Pharmaceuticals LP
$22
Tempus AI, Inc
$22
Gilead Sciences, Inc.
$20
EMD Serono, Inc.
$20
Exelixis Inc.
$19
Astellas Pharma US Inc
$18
TAIHO ONCOLOGY, INC.
$18
Stemline Therapeutics Inc.
$17
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$337
Novartis Pharmaceuticals Corporation
$293
PFIZER INC.
$226
GENZYME CORPORATION
$219
Celgene Corporation
$177
Gilead Sciences, Inc.
$169
AstraZeneca Pharmaceuticals LP
$165
E.R. Squibb & Sons, L.L.C.
$137
Genentech USA, Inc.
$121
PharmaEssentia USA Corporation
$84
Merck Sharp & Dohme LLC
$78
Myriad Genetic Laboratories, Inc.
$69
Incyte Corporation
$52
Alnylam Pharmaceuticals Inc.
$48
Astellas Pharma US Inc
$40
Janssen Biotech, Inc.
$35
Amneal Pharmaceuticals LLC
$27
Pharmacosmos Therapeutics Inc.
$26
ACCORD HEALTHCARE, INC.
$23
ARRAY BIOPHARMA INC
$22
Daiichi Sankyo Inc.
$22
Tempus AI, Inc
$22
Ipsen Biopharmaceuticals, Inc
$20
EMD Serono, Inc.
$20
Exelixis Inc.
$19
MorphoSys, US Inc.
$18
TAIHO ONCOLOGY, INC.
$18
Stemline Therapeutics Inc.
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
AVASTIN · BESREMI · BRAFTOVI · CABOMETYX · CALQUENCE · CAMCEVI · DARZALEX · ENHERTU · GAZYVA · IBRANCE · INJECTAFER · INLYTA · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · LONSURF · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · ONPATTRO · OPDIVO · Orserdu · PIQRAY · PLUVICTO · Perjeta · Pomalyst · REBLOZYL · SARCLISA · TAGRISSO · TECVAYLI · VERQUVO · VERZENIO · VOWST · VYNDAQEL · XTANDI · Xospata · Xtandi · Zydelig
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
17
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vugman is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vugman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Vugman performed 52,530 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vugman receive payments from pharmaceutical companies?
Yes. Dr. Vugman received a total of $2,521 from 29 companies across 74 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vugman's costs compare to other hematology & oncology specialists in Sarasota?
Dr. Vugman's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vugman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Sarasota
Browse hematology & oncology specialists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology